Press Releases
BEIJING, March 6, 2020 /PRNewswire/ -- Science and Technology Daily reported: A timeline clearly recorded how China has taken the initiative to fulfill its international responsibilities and unite with the global society to fight against Covid-19. After the coronavirus outbroke, China immediately in
Read more...6 March 2020
LAGUNA HILLS, Calif., March 6, 2020 /PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early stage breast cancer, announced today the presentation of multiple posters at the 37th Annual Miami Breast Cancer Conference. Prelude's proprietary tests stratify risk of recurrence of d
Read more...DALLAS, March 6, 2020 /PRNewswire/ -- Eyemart Express, a leading national optical retailer and home of the fastest glasses in the industry, is celebrating Women's History Month and Int
Read more...ROCHESTER, N.Y., March 6, 2020 /PRNewswire/ -- As innovations in cancer screening through diagnostic imaging continue to help clinicians accurately detect and diagnose, challenges to the ability to share large file sizes has increased.
Read more...LONDON, March 6, 2020 /PRNewswire/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today announced it signed a definitive agreement to acquire the rights to a por
Read more...– Topline data from Phase 3 NODE-301 trial of etripamil in patients with PSVT expected this month – MONTREAL and CHARLOTTE, N.C., March 6, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercializat
Read more...NORTH CHICAGO, Ill., March 6, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the European Commission has approved a change to the marketing authorization for MAVIRET® (glecaprevir/pibrentasvir) to shorten once-daily treatment duration from 12 to 8 weeks in treatment-naïve, compensated
Read more...STOCKHOLM, March 6, 2020 /PRNewswire/ -- Safeture AB today said it is offering its employee safety software to any company looking to track the potential exposure of their workers to the coronavirus now impacting countries around the world. Identifying which employees have been in high-risk areas is critical to effectively containing the spread of the sickness.
Read more...6 March 2020
SINGAPORE, March 6, 2020 /PRNewswire/ -- In light of global concerns due to the on-going Novel Coronavirus (COVID-19) situation, Informa Markets, organiser of ConnecTechAsia, is postponing the 2020 edition to 29 September - 1 October 2020 at the Singapore EXPO & MAX Atria. The event was originally scheduled for 9 - 11 Ju
Read more...6 March 2020
UPPSALA, Sweden, March 6, 2020 /PRNewswire/ -- Orexo AB (publ), today announces it has submitted an application to the US Food and Drug Administration (FDA) for vorvida® to enable commercialization in the US. vorvida®, is a digital therapy with clinically proven efficacy for the treatment of bothersome or harmf
Read more...